CAR-T ICU 2019 | Neurology needs: preparing neurologists for CAR-T

Robert Hadden

Robert Hadden, BM BCh, FRCP, PhD, King’s College Hospital, London, UK, discusses future directions for managing symptoms of neurotoxicity in CAR T-cell treated patients. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.

Share this video